Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-10T05:16:11.408Z Has data issue: false hasContentIssue false
  • English
  • Français

Suicidal ideation and attempts following nonmedical use of prescription opioids and related disorder

Published online by Cambridge University Press:  08 July 2020

Julian Santaella-Tenorio Open the ORCID record for Julian Santaella-Tenorio [Opens in a new window] ,
Silvia S. Martins ,
Magdalena Cerdá ,
Mark Olfson  and
Katherine M. Keyes
Julian Santaella-Tenorio*
Affiliation:
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
Silvia S. Martins
Affiliation:
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
Magdalena Cerdá
Affiliation:
Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, NYU, New York, NY
Mark Olfson
Affiliation:
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, USA New York State Psychiatric Institute, New York, New York, USA
Katherine M. Keyes
Affiliation:
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA Society and Health Research Center, Facultad de Humanidades, Universidad Mayor, Santiago, Chile
*
Author for correspondence: Julian Santaella-Tenorio, E-mail: js4222@columbia.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Since 1999, the rate of fatal prescription opioid overdoses and of suicides has dramatically increased in the USA. These increases, which have occurred among similar demographic groups, have led to the hypothesis that the opioid epidemic contributed to increases in suicidal behavior, though the underlying association remains poorly defined. We examine the association between nonmedical use of prescription opioids/opioid use disorder and suicidal ideation/attempts.

Methods

We used longitudinal data from a national representative sample of the US adult population, the National Epidemiologic Survey on Alcohol and Related Conditions. Participants (n = 34 653) were interviewed in 2001–2002 (wave 1) and re-interviewed approximately 3 years later (wave 2). A propensity score analysis estimated the association between exposure to prescription opioids at wave 1 and prevalent/incident suicidal behavior at wave 2.

Results

Heavy/frequent (⩾2–3 times a month) prescription opioid use was associated with prevalent suicide attempts [adjusted risk ratio (ARR) = 2.75, 95% CI 1.35–5.60]. Prescription opioid use disorder was associated with prevalent (ARR = 1.98, 95% CI 1.20–3.28) and incident suicidal ideation (ARR = 2.59, 95% CI 1.25–5.37), and prevalent attempts (ARR = 4.19, 95% CI 1.71–10.27). None of the exposures was associated with incident suicide attempts.

Conclusions

Heavy/frequent opioid use and related disorder were associated with prevalent suicide attempts; opioid use disorder was also associated with the incident and prevalent suicidal ideation. Given population increases in nonmedical use of prescription opioids and disorder, the opioid crisis may have contributed to population increases in suicidal ideation.

Keywords

Attempted suicidedependenceopioid abuseopioid-related disordersuicidal ideation
Type
Original Article
Information
Psychological Medicine , Volume 52 , Issue 2 , January 2022 , pp. 372 - 378
Check for updates
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Association (https://doi.org/10.1176/appi.books.9780890425596). Accessed 30 January 2020.Google Scholar
Bohnert, A. S. B., & Ilgen, M. A. (2019). Understanding links among opioid use, overdose, and suicide. The New England Journal of Medicine, 380, 71–79.CrossRefGoogle ScholarPubMed
Boudreau, D., Von Korff, M., Rutter, C. M., Saunders, K., Ray, G. T., Sullivan, M. D., … Weisner, C. (2009). Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiology & Drug Safety, 18, 1166–1175.CrossRefGoogle ScholarPubMed
Center for Substance Abuse Treatment (2004). Chapter 2: Impact of Substance Abuse on Families. Treatment Improvement Protocol (TIP) Series, No. 39. Rockville (MD): Substance Abuse and Mental Health Services Administration (US).Google Scholar
Curtin, S., Warner, M., & Hedegaard, H. (2016). Increase in suicide in the United States, 1999–2014. NCHS data brief, No. 241.Hyattsville, MD: National Center for Health Statistics (https://www.cdc.gov/nchs/data/databriefs/db241.pdf). Accessed 8 September 2019.Google Scholar
D'Agostino, R. J. (1998). Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Statistics in Medicine, 17, 2265–2281.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
Dugoff, E. H., Schuler, M., & Stuart, E. A. (2014). Generalizing observational study results: Applying propensity score methods to complex surveys. Health Services Research, 49, 284–303.CrossRefGoogle ScholarPubMed
Ford, J. A., & Perna, D. (2015). Prescription drug misuse and suicidal ideation: Findings from the national survey on drug use and health. Drug and Alcohol Dependence, 157, 192–196.CrossRefGoogle ScholarPubMed
Gardner, E. L. (2011). Addiction and brain reward and antireward pathways. Advances in Psychosomatic Medicine, 30, 22–60.CrossRefGoogle ScholarPubMed
Garland, E. L., Froeliger, B., Zeidan, F., Partin, K., & Howard, M. O. (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways. Neuroscience & Biobehavioral Reviews, 37, 2597–2607.CrossRefGoogle ScholarPubMed
Garland, E. L., Hanley, A. W., Thomas, E. A., Knoll, P., & Ferraro, J. (2015). Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids. Journal of Addiction Medicine, 9, 61–67.CrossRefGoogle ScholarPubMed
Grant, B. F., Harford, T. C., Dawson, D. A., Chou, P. S., & Pickering, R. P. (1995). The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): Reliability of alcohol and drug modules in a general population sample. Drug and Alcohol Dependence, 39, 37–44.CrossRefGoogle Scholar
Grant, B. F., Kaplan, K., Shepard, J., & Moore, T. (2003). Source and accuracy statement: Wave 1 national epidemiologic survey on alcohol and related conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.Google Scholar
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., … Kaplan, K. (2004a). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders – results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 807–816.CrossRefGoogle ScholarPubMed
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004b). Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archves of General Psychiatry, 61, 361–368.CrossRefGoogle ScholarPubMed
Greenland, S., & Mickey, R. M. (1989). Re: “The impact of confounder selection criteria on effect estimation”. American Journal of Epidemiology, 130, 1066.CrossRefGoogle Scholar
Guo, L., Xu, Y., Den, J., Huang, J., Huang, G., Gao, X., … Lu, C. (2016). Association between nonmedical use of prescription drugs and suicidal behavior among adolescents. JAMA Pediatrics, 170, 971–978.CrossRefGoogle ScholarPubMed
Hasin, D. S., & Grant, B. F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) waves 1 and 2: Review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50, 1609–1640.CrossRefGoogle ScholarPubMed
Hedegaard, H., Warner, M., & Miniño, A. (2017). Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, No. 294. Hyattsville, MD: National Center for Health Statistics (https://www.cdc.gov/nchs/data/databriefs/db294.pdf). Accessed 8 September 2019.Google Scholar
Hom, M. A., Joiner, T. E., & Bernert, R. A. (2016). Limitations of a single-item assessment of suicide attempt history: Implications for standardized suicide risk assessment. Psychological Assessment, 28, 1026–1030.CrossRefGoogle ScholarPubMed
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural mechanisms of addiction: The role of reward-related learning and memory. Annual Review of Neuroscience, 29, 565–598.CrossRefGoogle ScholarPubMed
Ilgen, M. A., Bohnert, A. S., Ganoczy, D., Bair, M. J., McCarthy, J. F., & Blow, F. C. (2016). Opioid dose and risk of suicide. Pain, 157, 1079–1084.CrossRefGoogle ScholarPubMed
Kegler, S. R., Stone, D. M., & Holland, K. M. (2017). Trends in suicide by level of urbanization – United States, 1999–2015. Morbidity and Mortality Weekly Report, 66, 270–273.CrossRefGoogle ScholarPubMed
Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97–129.CrossRefGoogle ScholarPubMed
Kuramoto, S. J., Chilcoat, H. D., Ko, J., & Martins, S. S. (2012). Suicidal ideation and suicide attempt across stages of nonmedical prescription opioid use and presence of prescription opioid disorders among US adults. Journal of Studies on Alcohol and Drugs, 73, 178–184.CrossRefGoogle Scholar
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2, 1–68. CD002207. doi:10.1002/14651858.CD002207.pub4.Google Scholar
Millner, A. J., Lee, M. D., & Nock, M. K. (2015). Single-Item measurement of suicidal behaviors: Validity and consequences of misclassification. PLoS One, 10, e0141606.CrossRefGoogle ScholarPubMed
Oakes, J., & Johnson, P. (2006). Propensity score matching for social epidemiology. Chapter 15. In Oakes, J., & Kaufman, J. (Eds.), Methods in social epidemiology (pp. 364–386). San Francisco, CA: Jossey/Bass-Wiley.Google Scholar
Olfson, M., Blanco, C., Wall, M., Liu, S. M., Saha, T. D., Pickering, R. P., & Grant, B. F. (2017). National trends in suicide attempts among adults in the United States. JAMA Psychiatry, 74, 1095–1103.CrossRefGoogle ScholarPubMed
Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70, 41–55.CrossRefGoogle Scholar
Rosenbaum, P. R., & Rubin, D. B. (1985). Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score. American Statistician, 39, 33–38.Google Scholar
Ruan, W. J., Goldstein, R. B., Chou, S. P., Smith, S. M., Saha, T. D., Pickering, R. P., … Grant, B. F. (2008). The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): Reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug and Alcohol Dependence, 92, 27–36.CrossRefGoogle Scholar
Samples, H., Stuart, E. A., & Olfson, M. (2019). Opioid Use and Misuse and Suicidal Behaviors in a Nationally Representative Sample of US Adults. American Journal of Epidemiology, 188, 1245–1253.CrossRefGoogle Scholar
Scherrer, J. F., Svrakic, D. M., Freedland, K. E., Chrusciel, T., Balasubramanian, S., Bucholz, K. K., … Lustman, P. J. (2013). Prescription opioid analgesics increase the risk of depression. Journal of General Internal Medicine, 29, 491–499.CrossRefGoogle ScholarPubMed
StataCorp (2015). Stata statistical software: Release 14. College Station, TX: StataCorp LP.Google Scholar
Stoliker, B. E. (2018). Attempted suicide: A multilevel examination of inmate characteristics and prison context. Criminal Justice and Behavior, 45, 589–611.CrossRefGoogle Scholar
Striebel, J. M., & Kalapatapu, R. K. (2014). The anti-suicidal potential of buprenorphine: A case report. The International Journal of Psychiatry in Medicine, 47, 169–174.CrossRefGoogle ScholarPubMed
Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration (https://www.samhsa.gov/data/). Accessed 8 September 2019.Google Scholar
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies--tackling the opioid-overdose epidemic. New England Journal of Medicine, 370, 2063–2066.CrossRefGoogle ScholarPubMed
Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004). Association of alcohol and drug use disorders and completed suicide: An empirical review of cohort studies. Drug and Alcohol Dependence, 76, S11–S19.CrossRefGoogle ScholarPubMed
Williamson, E., Morley, R., Lucas, A., & Carpenter, J. (2012). Propensity scores: From naive enthusiasm to intuitive understanding. Statistical Methods in Medical Research, 21, 273–293.CrossRefGoogle ScholarPubMed
Yovell, Y., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherov, J., … Panksepp, J. (2016). Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: A randomized controlled trial. American Journal of Psychiatry, 173, 491–498.CrossRefGoogle ScholarPubMed
Zullig, K. J., Divin, A. L., Weiler, R. M., Haddox, J. D., & Pealer, L. N. (2015). Adolescent nonmedical use of prescription pain relievers, stimulants, and depressants, and suicide risk. Substance Use & Misuse, 50, 1678–1689.CrossRefGoogle ScholarPubMed
Supplementary material: File

Santaella-Tenorio et al. supplementary material

Tables S1-S4

Download Santaella-Tenorio et al. supplementary material(File)
File 232 KB